RecruitingPHASE1, PHASE2NCT06833320
Propranolol Treatment for Postoperative Chylothorax
Studying Congenital chylothorax
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- June Wu
- Principal Investigator
- June Wu, MD, M.DColumbia University Irving Medical Center/ New York Presbyterian hospital
- Intervention
- Propranolol Hydrochloride(drug)
- Enrollment
- 50 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2031
Study locations (1)
- Columbia University Irving Medical Center/NewYork-Presbyterian, New York, New York, United States
Collaborators
United States Department of Defense
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06833320 on ClinicalTrials.govOther trials for Congenital chylothorax
Additional recruiting or active studies for the same condition.